Texas Patent of the Month – February 2024
Trained Therapeutix Discovery, Inc is leveraging trained immunity and modern nanobiologic therapeutics to treat even the most detrimental of diseases. Trained immunity involves reprogramming of the innate immune cells at the metabolic level. By leveraging immune memory, the company hijacks the body’s natural mechanisms to engage the immune system with nanobiologics.
Recently, the company has been granted a patent for compounds used in their trained immunity platform. The formula is designed with a unique structure with multiple variable groups allowing for precise customization.
At its core, the invention taps into the innate immune system, specifically targeting the NOD2 receptor. Trained immunity, a recently explored facet of the immune system, involves the reprogramming of innate immune cells for enhanced functionality. Trained Therapeutix Discovery’s compound engages pattern recognition receptors (PRRs) like NOD2 to trigger and modulate trained immunity effectively.
The compound’s versatility is evident in its molecular architecture. R1, R2, R3, and other substituents can be tailored to achieve optimal therapeutic effects. This flexibility ensures the customization of the compound for different applications, making it a promising candidate for treating atherosclerosis, diabetes, and cancer.
The invention further extends to nanobiologic compositions, incorporating the compound into high-density lipoprotein (HDL)-derived nanoparticles. These nanoparticles, enriched with phospholipids and cholesterol, create an ideal environment for the compound’s delivery, ensuring its bioavailability to target myeloid cells and their progenitors.
In preclinical studies, Trained Therapeutix Discovery’s compound demonstrated its potential as a therapeutic agent, regulating trained immunity without the adverse effects associated with existing immunotherapies. The compound’s nanobiologic formulations pave the way for innovative treatment modalities, offering a new frontier in the field of immunotherapy.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state










